Skip to main content
Move the World.
rna editing

Lead Image © subphoto / Adobe Stock

Lost in the long shadow of its DNA-snipping cousin CRISPR for nearly a decade, RNA editing is having a moment — a $91.5 million moment.

That's the recently closed Series A round for RNA editing startup Korro Bio, the Cambridge-based company inspired by ... squid.

Korro co-founder Joshua Rosenthal, a neurobiologist at the Marine Biological Laboratory in Woods Hole, Massachusetts, has dedicated the bulk of his career to studying the nervous systems of squids, Ryan Cross wrote in a thorough 2019 piece for Chemical & Engineering News

Squids — which are objectively awesome — utilize an enzyme called ADAR ("adenosine deaminase acting on RNA") to edit their own RNA. 

Rosenthal saw a potentially powerful therapeutic tool.

Editing with Pencil, Not Ink

CRISPR still elicits sharp inhales of excitement, the punctuations of giddy progress and promise, and rightfully so; a dazzling array of DNA projects are underway. 

CRISPR has its downsides, though, perhaps most frighteningly the potential to cause permanent — and unintended — gene mutations. Basically, CRISPR can be hitting genes in places we don't want it to, and those changes are permanent, passed down by the cell in every copy of itself. 

RNA editing avoids this concern by changing the expression of genes only temporarily.

If DNA is the blueprint for our bodies, RNA is the work orders, converting the master plan in the cell's nucleus into specific instructions on what proteins to build, and when. While CRISPR is modifying your building plan (for instance, erasing disease-causing genes), RNA editing is just intercepting your cells' work orders.

Like CRISPR, editing RNA needs "guide RNA" and an enzyme to make changes to a specific target. When cutting DNA with CRISPR, that enzyme is usually Cas9; with RNA editing, it's ADAR. Guided by a strand of RNA that's inserted into the body, the ADAR enzyme can change one specific letter of the RNA work orders, which then results in cells cranking out different proteins.

Change the correctly placed letter, get your desired result.

The key safety consideration is that the editing has to be done continuously to still have an effect. When the ADAR-modified RNA gets used up, the body will go back to its master plan (DNA) to create RNA — no permanent changes.

This means RNA editing offers some unique potential: it can be used to treat genetic disorders without the looming fear of forever altering your genes, and could perhaps help treat transient problems, like inflammation and pain.

RNA Editing's Return

RNA editing in and of itself isn't new; per Labiotech, the technique was first laid out in the late 1980s, and it was studied as a possible form of therapy in the 1990s, when it was investigated as a treatment for muscular dystrophy. 

(A research paper came out of the whole thing, according to Cross, but was cited once, and then the field evaporated.)

RNA editing has unique potential to treat genetic disorders without the fear of forever altering genes.

But the approval by regulatory bodies of an RNA interference drug in 2018 — silencing the expression of a gene, without permanently deleting it — reignited interest in the technique.

RNA editing does pose some challenges. ADAR naturally occurs in the human body — we don't use it as adroitly as the squids do — and thus the ADAR doesn't need to be delivered into us like Cas9 does; only the special guide RNA, which wrangles the ADAR and takes it where we want it, needs to be put inside. But RNA is a pretty unstable lil molecule, and, if it's floating around freely, it runs the risk of being set upon by the immune system. 

The highly specific nature of ADAR — only changing one letter — also means that RNA editing is working with a more limited tool box than CRISPR, although researchers are working on that.

Up Next

CRISPR
Small Protein, Big Breakthrough for CRISPR Gene Editing
crispr gene editing
CRISPR
Small Protein, Big Breakthrough for CRISPR Gene Editing
A new protein opens doors for gene editing by gaining access to hard-to-reach areas of the genome.

A new protein opens doors for gene editing by gaining access to hard-to-reach areas of the genome.

Dispatches
CRISPR Edits Out Autistic Traits in Mice
CRISPR Edits Out Autistic Traits in Mice
Dispatches
CRISPR Edits Out Autistic Traits in Mice
The technique could also open up treatments for Huntington's, schizophrenia, and epilepsy.

The technique could also open up treatments for Huntington's, schizophrenia, and epilepsy.

CRISPR
CRISPR Virus Detection Tool Can Test You for 169 Viruses at Once
Virus Detection
CRISPR
CRISPR Virus Detection Tool Can Test You for 169 Viruses at Once
A new virus detection tool can simultaneously test more than 1,000 patients for a virus — a capability that could prove invaluable during an outbreak.

A new virus detection tool can simultaneously test more than 1,000 patients for a virus — a capability that could prove invaluable during an outbreak.

CRISPR
Scientists Use CRISPR to Reverse Diabetes in Mice
reverse diabetes
CRISPR
Scientists Use CRISPR to Reverse Diabetes in Mice
Scientists have used CRISPR to correct a diabetes-causing mutation in stem cells and then use those cells to reverse diabetes in mice.

Scientists have used CRISPR to correct a diabetes-causing mutation in stem cells and then use those cells to reverse diabetes in mice.

Astronomy
Fresh Ice Spotted In Unexpected Part of Saturn's Moon Enceladus
Enceladus
Astronomy
Fresh Ice Spotted In Unexpected Part of Saturn's Moon Enceladus
Saturn’s moon Enceladus is already suspected of hosting extraterrestrial life, and new Cassini data suggests where that life might exist.

Saturn’s moon Enceladus is already suspected of hosting extraterrestrial life, and new Cassini data suggests where that life might exist.

Medicine
RNA Vaccines Could Change Everything in the Fight Against Disease
RNA Vaccines Could Change Everything in the Fight Against Disease
Medicine
RNA Vaccines Could Change Everything in the Fight Against Disease
Traditional methods of vaccination have come up against difficult challenges. They can also be expensive and time-consuming to produce. New RNA vaccines are faster, cheaper, and safer, and show great potential to meet evolving threats.

Traditional methods of vaccination have come up against difficult challenges. They can also be expensive and time-consuming to produce, curtailing efforts to control outbreaks or head off a flu season caused by an unexpected strain. A newer type of vaccines, using RNA, could alleviate these issues. Faster, cheaper, and safer, RNA vaccines show great potential to meet evolving threats.

Dispatches
Neuroscientists Want to Beam Experiences Directly into Your Brain
Neuroscientists Want to Beam Experiences Directly into Your Brain
Dispatches
Neuroscientists Want to Beam Experiences Directly into Your Brain
It's a breakthrough for the blind and paralyzed, not the first step toward the Matrix. (Promise.)

It's a breakthrough for the blind and paralyzed, not the first step toward the Matrix. (Promise.)

Coded
Disrupting Money
Disrupting Money
Watch Now
Coded
Disrupting Money
Can a bitcoin entrepreneur on house arrest convince the world it’s the currency of the future?
Watch Now

Charlie Shrem went from multi-millionaire to having almost nothing. Shrem was a Bitcoin pioneer. And it paid off big time. Until he was sent to jail for allowing a customer to resell bitcoin on Silk Road. Now, he’s out and wants to convince the world that Bitcoin is the future of finance.